CG Oncology (NASDAQ:CGON) Earns Sector Perform Rating from Analysts at Scotiabank
Scotiabank assumed coverage on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research note published on Wednesday morning, MarketBeat Ratings reports. The firm issued a sector perform rating and a $23.00 target price on the stock. A number of other research firms also recently commented on CGON. HC Wainwright reiterated a “buy” rating […]
Scotiabank assumed coverage on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research note published on Wednesday morning, MarketBeat Ratings reports. The firm issued a sector perform rating and a $23.00 target price on the stock. A number of other research firms also recently commented on CGON. HC Wainwright reiterated a “buy” rating […]